View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Infectious Diseases News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 02, 2024
2 min read
Save

Postpartum visits ‘missed opportunity’ to incorporate HPV vaccination into care

Postpartum visits ‘missed opportunity’ to incorporate HPV vaccination into care

The addition of HPV vaccination into routine postpartum care may increase vaccination rates, which can reduce patient costs, prevent HPV-related cancers and vaccinate vulnerable populations, researchers reported in Obstetrics & Gynecology.

SPONSORED CONTENT
October 01, 2024
2 min read
Save

Brazil is latest country to eliminate lymphatic filariasis

Brazil is latest country to eliminate lymphatic filariasis

Brazil became the 20th country or territory in the world to eliminate lymphatic filariasis as a public health crisis after nearly 3 decades of efforts to stop the painful, disfiguring parasitic infection, according to WHO.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
October 01, 2024
1 min read
Save

Top in ID: Color additive for disinfectant wipes; At-home STI testing for young people

Top in ID: Color additive for disinfectant wipes; At-home STI testing for young people

A pre-post-quasi-experimental study conducted at Griffin Hospital in Derby, Connecticut, revealed that using disinfectant wipes treated with a novel color additive left hospital rooms 69.2% cleaner than using regular bleach wipes.

SPONSORED CONTENT
September 30, 2024
2 min read
Save

Rwanda confirms its first Marburg virus outbreak

Rwanda confirms its first Marburg virus outbreak

Rwanda’s Ministry of Health confirmed 26 cases and six deaths in a growing outbreak of Marburg virus, a severe viral hemorrhagic virus spread by bats in some African countries.

SPONSORED CONTENT
September 29, 2024
2 min read
Save

‘Very little evidence’ that COVID-19 alters course of rheumatic, autoimmune diseases

‘Very little evidence’ that COVID-19 alters course of rheumatic, autoimmune diseases

SAN DIEGO — Although a flood of COVID-19 and long COVID research continues to emerge, concerns may be limited for rheumatologists, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
September 27, 2024
1 min read
Save

Death risk for hospitalized older adults higher with RSV than flu B

Death risk for hospitalized older adults higher with RSV than flu B

Older adults’ risk for death when hospitalized with respiratory syncytial virus is higher than it is for influenza B but similar to influenza A, according to a study.

SPONSORED CONTENT
September 27, 2024
5 min read
Save

Lessening the ‘ick’ in fecal microbiota-based therapies

Lessening the ‘ick’ in fecal microbiota-based therapies

Fecal microbiota-based therapies are becoming more prevalent in the management of Clostridioides difficile infection.

SPONSORED CONTENT
September 26, 2024
2 min read
Save

CDC awards $176M for public health infrastructure, workforce improvements

CDC awards $176M for public health infrastructure, workforce improvements

The CDC announced that it has awarded more than $176 million to 48 public health partners to strengthen the public health infrastructure and workforce in the United States.

SPONSORED CONTENT
September 26, 2024
2 min read
Save

'Encouraging': Antiviral ziresovir shows promise against RSV in infants

'Encouraging': Antiviral ziresovir shows promise against RSV in infants

The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New England Journal of Medicine.

SPONSORED CONTENT
September 24, 2024
1 min read
Save

Top in ID: First self-administered influenza vaccine; Reducing severe COVID-19 symptoms

Top in ID: First self-administered influenza vaccine; Reducing severe COVID-19 symptoms

The FDA approved FluMist, a nasal spray vaccine, for self-administration in people aged 2 to 49 years, making it the first ever influenza vaccine that does not need to be administered by a health care professional, the FDA announced.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails